The study found significant intra-group CMT reductions in the DEX-I group, with a higher percentage reduction than the ...

Breakthrough therapy designation granted as Company advances the PIONEER registrational program in optic neuropathies to create a potential ...

Handgrip strength is inversely linked to the incidence of age-related macular degeneration, according to a study published online Dec. 5 in Aging Clinical and Experimental Research. Shuoyang Wang, ...

Academy and Tony Award-winning actress Judi Dench detailed the realities of her eye condition, which has led to a loss of sight and her stepping back from the stage and screen. “No, you don’t [see me ...

What Is Eylea HD, and Why Does It Matter? Eylea HD (aflibercept) is an injectable medicine used to treat certain eye conditions that can lead to vision loss. It works by blocking a protein called VEGF ...

Please provide your email address to receive an email when new articles are posted on . The decision is supported by positive visual acuity gains found in the phase 3 QUASAR trial. This is the fourth ...

After months of back-and-and forth with the FDA and a third-party manufacturer, Regeneron has secured two long-awaited approvals for Eylea HD, gaining a new indication and a more flexible dosing ...

Regeneron has settled its patent dispute with Celltrion, giving the go-ahead for another biosimilar to its blockbuster eye drug Eylea (aflibercept) to hit the U.S. market in just over a year. The deal ...

Of the 38 patients with age-related macular degeneration, 80% were able to read again after having the eye implant and using the glasses. When you purchase through links on our site, we may earn an ...

Roche is forging ahead with plans to seek approval for an eye disease drug candidate despite missing the primary endpoint in one of its phase 3 trials. The Swiss drugmaker ran two identical studies, ...

The device could help a million people with a severe form of macular degeneration to be able to see enough to read. By Gina Kolata For the first time, researchers restored some vision to people with a ...